Biora Therapeutics, Inc.
BIOROTCHealthcare
$0.22
+$0.00(+0.00%)
Market Cap$994994
P/E Ratio—
52W High$0.3802
52W Low$0.15
Biora Therapeutics, Inc. (BIOR) · Income Statement
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · BIOR · as of 2026-06-09
Financial statements
Revenue · Gross Profit · Net Income
| Breakdown | 2023-12 | 2022-12 | 2021-12 | 2020-12 | 2019-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $0.00M | $0.30M | $1.25M | $74.31M | $143.99M |
| Cost of Revenue | $0.00M | $0.00M | $0.00M | $93.43M | $100.49M |
| Gross Profit | $0.00M | $0.30M | $1.25M | ($19.12M) | $43.49M |
| Gross Margin %(computed) | 100.00% | 100.00% | 100.00% | -25.73% | 30.21% |
| Operating Expenses | |||||
| R&D Expenses | $29.84M | $24.05M | $45.78M | $47.74M | $63.40M |
| G&A Expenses | $0.00M | $0.00M | $68.54M | $75.44M | $61.32M |
| Total Operating Expenses | $67.15M | $62.09M | $119.08M | $176.07M | $183.61M |
| Operating Income | ($67.14M) | ($61.78M) | ($117.84M) | ($107.62M) | ($140.12M) |
| Operating Margin %(computed) | — | — | — | -144.82% | -97.31% |
| Interest Income | $0.00M | $0.00M | $0.00M | $0.00M | $0.57M |
| Interest Expense | $9.81M | $10.99M | $12.64M | $9.91M | $9.20M |
| Income Before Tax | ($124.42M) | ($49.25M) | ($178.64M) | ($142.62M) | ($148.74M) |
| Income Tax Expense | ($0.09M) | ($0.42M) | ($0.12M) | ($37.53M) | ($0.71M) |
| Net Income | ($124.11M) | ($38.16M) | ($178.52M) | ($192.53M) | ($148.04M) |
| Net Margin %(computed) | — | — | — | -259.08% | -102.81% |
| Per Share & EBITDA | |||||
| EPS (Basic) | $-78.70 | $-6.40 | $-46.42 | $-86.30 | $-80.17 |
| Wtd Avg Shares | 1.58M | 0.76M | 0.38M | 0.22M | 0.18M |
| EBITDA | ($114.05M) | ($37.35M) | ($164.57M) | ($106.18M) | ($135.44M) |
| EBITDA Margin %(computed) | — | — | — | -142.88% | -94.07% |
Data source: Financial Modeling Prep · Last updated: 2026-06-09 · USD · M
Explore more Biora Therapeutics, Inc. data
About Biora Therapeutics, Inc. (BIOR) Income Statement
Biora Therapeutics, Inc. (BIOR) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2023, BIOR reported revenue of $0.00B, gross profit of $0.00B (gross margin 100.00%), and net income of ($0.12B) — a net profit margin of -3102875.00%.
Frequently asked questions
BIOR · 4 questionsBiora Therapeutics, Inc. (BIOR) reported revenue of $0.00B for 2023, down 98.7% year-over-year.
BIOR revenueBIOR salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-09